Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel polypeptide and use in diagnosis, treatment of cancer

April 25, 2001

TNFerade expected to have wide safety margin in humans based on murine data

April 25, 2001

Tricyclic PARP inhibitors and use in cancer therapy and for neurotoxicity Rx

April 24, 2001

NB-506 maintains activity against camptothecin-resistant human leukemia cells

April 24, 2001

Naja venom fraction induces apoptosis in human leukemia cells

April 23, 2001

Vical discontinues current Leuvectin trial in kidney cancer and plans new trial

April 23, 2001

Cotara enters additional trial for liver cancer

April 23, 2001

Patient dosing begins in phase I trial of intravenous IL-2 gene medicine

April 23, 2001

Urokinase inhibitors synthesized at Abbott; compositions and methods of use described

April 23, 2001

Topoisomerase I and II inhibitor conjugates jointly designed by U.S. universities

April 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...